Surgery Partners, Inc. (SGRY)

NASDAQ: SGRY · IEX Real-Time Price · USD
38.39
+0.69 (1.83%)
Aug 15, 2022 4:00 PM EDT - Market closed
1.83%
Market Cap 3.45B
Revenue (ttm) 2.38B
Net Income (ttm) -29.20M
Shares Out 89.94M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE 200.00
Dividend n/a
Ex-Dividend Date n/a
Volume 204,574
Open 37.42
Previous Close 37.70
Day's Range 36.68 - 38.42
52-Week Range 26.66 - 63.87
Beta 2.87
Analysts Buy
Price Target 64.15 (+67.1%)
Earnings Date Aug 2, 2022

About SGRY

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services... [Read more...]

Industry Health Care Providers & Services
IPO Date Oct 1, 2015
CEO J. Eric Evans
Employees 8,300
Stock Exchange NASDAQ
Ticker Symbol SGRY
Full Company Profile

Financial Performance

In 2021, SGRY's revenue was $2.23 billion, an increase of 19.62% compared to the previous year's $1.86 billion. Losses were -$70.90 million, -38.93% less than in 2020.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price forecast is 64.15, which is an increase of 67.10% from the latest price.

Price Target
$64.15
(67.10% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Surgery Partners (SGRY) Reports Q2 Loss, Misses Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of 0% and 1.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners, Inc. Announces Second Quarter 2022 Results

BRENTWOOD, Tenn., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the s...

Surgery Partners, Inc. Announces Second Quarter 2022 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., June 29, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the C...

Surgery Partners, Inc. to Present at Upcoming Investor Conference

BRENTWOOD, Tenn., June 02, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Jefferies Healthcare Conference...

Surgery Partners, Inc. to Present at Upcoming Investor Conferences

BRENTWOOD, Tenn., May 04, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the following healthcare conferences:

Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -80% and 2.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SURGERY PARTNERS, INC. AND VALUEHEALTH, LLC ANNOUNCE STRATEGIC PARTNERSHIP

BRENTWOOD, Tenn. and KANSAS CITY, Mo.

Surgery Partners, Inc. Announces First Quarter 2022 Results

BRENTWOOD, Tenn., May 03, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the fi...

Surgery Partners, Inc. Announces First Quarter 2022 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the ...

Surgery Partners (SGRY) Misses Q4 Earnings and Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -11.54% and 2.51%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2021 Results; Raises 2022 Guidance

BRENTWOOD, Tenn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the f...

Wall Street Analysts Predict a 35% Upside in Surgery Partners (SGRY): Here's What You Should Know

The consensus price target hints at a 34.6% upside potential for Surgery Partners (SGRY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es...

Surgery Partners (SGRY) Reports Next Week: Wall Street Expects Earnings Growth

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Surgery Partners (SGRY) Climb 40% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 39.5% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, the...

Surgery Partners, Inc. Announces Fourth Quarter 2021 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the C...

Surgery Partners Enters Strategic Partnership with Privia Health in the State of Montana

BRENTWOOD, Tenn. and ARLINGTON, Va., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) and Privia Health Group, Inc. (Nasdaq: PRVA) today announced a strategic agreement whereby Su...

Save Your Portfolio by Getting Rid of These 4 Toxic Stocks

Investors who can spot the overpriced stocks and shun them at the right time are the ones likely to make a profit. SGRY, ASAI, BLKB and AZTA are a few toxic stocks that you should disown right away.

Other symbols: ASAIAZTABLKB

Surgery Partners, Inc. Announces Pricing of $279.0 million Public Offering of Common Stock

BRENTWOOD, Tenn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its previously announced underwritten public offering of 6,0...

Surgery Partners, Inc. Announces Proposed Public Offering of Common Stock

BRENTWOOD, Tenn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 5,000,000 shares o...

Surgery Partners (SGRY) Reports Q3 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -25.00% and 0.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners, Inc. Announces Third Quarter 2021 Results

BRENTWOOD, Tenn., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the t...

Surgery Partners (SGRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgery Partners, Inc. Announces Third Quarter 2021 Earnings Release Date and Conference Call Details

BRENTWOOD, Tenn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the C...

5 Medical Services Stocks Countering Industry Headwinds

The Zacks Medical - Services industry is growing on digital healthcare adoption. HQY, PGNY, SGRY, MODV, and AGTI are set to gain the most.

Other symbols: AGTIHQYMODVPGNY

Down 26.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Surgery Partners (SGRY)

Surgery Partners (SGRY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings esti...